189 related articles for article (PubMed ID: 17543428)
21. A seroprevalence study of poliovirus antibody in the population of northern Greece.
Frantzidou F; Diza E; Halkia D; Antoniadis A
Clin Microbiol Infect; 2005 Jan; 11(1):68-71. PubMed ID: 15649308
[TBL] [Abstract][Full Text] [Related]
22. Assessment of poliovirus antibody seroprevalence in polio high risk areas of West Africa.
Guindo O; Mach O; Doumbia S; Ekra DK; Beavogui AH; Weldon WC; Oberste MS; Sutter RW
Vaccine; 2018 Feb; 36(8):1027-1031. PubMed ID: 29358054
[TBL] [Abstract][Full Text] [Related]
23. Epidemiological serosurvey of poliovirus in Guangdong, China: A cross-sectional study.
Tan Q; Zhu Q; Zheng H; Zhang B; Wu C; Guo X; Li H; Liu L; Liu Y; Rutherford S; Zheng H
Hum Vaccin Immunother; 2018; 14(11):2644-2648. PubMed ID: 30059644
[TBL] [Abstract][Full Text] [Related]
24. Deficiency of immunity to poliovirus type 3: a lurking danger?
Reinheimer C; Friedrichs I; Rabenau HF; Doerr HW
BMC Infect Dis; 2012 Jan; 12():24. PubMed ID: 22280025
[TBL] [Abstract][Full Text] [Related]
25. Sero-survey of polio antibodies and quality of acute flaccid paralysis surveillance in Chongqing, China: A cross-sectional study.
Xu J; Kuang S; Rong R; Zhang Y; Tang W; Wang Q
Medicine (Baltimore); 2020 Jul; 99(31):e21298. PubMed ID: 32756110
[TBL] [Abstract][Full Text] [Related]
26. Seroprevalence of Anti-polio Antibodies in Children From Polio High-risk Areas of Pakistan: A Cross-Sectional Survey 2015-2016.
Hussain I; Mach O; Habib A; Bhatti Z; Suhag Z; Oberste MS; Weldon WC; Sutter RW; Soofi SB; Bhutta ZA
Pediatr Infect Dis J; 2017 Sep; 36(9):e230-e236. PubMed ID: 28806355
[TBL] [Abstract][Full Text] [Related]
27. Polio type 2 and 3 eradication: Relevance to the immunity status of individuals living in Germany, 2005-2020.
Kohmer N; Rabenau HF; Rilling V; Ciesek S; Enders M; Eggers M
J Clin Virol; 2023 Jul; 164():105471. PubMed ID: 37130476
[TBL] [Abstract][Full Text] [Related]
28. Assessment of seroprevalence against poliovirus among Italian adolescents and adults.
Lupi S; Stefanati A; Baldovin T; Roman A; Baldo V; Gabutti G
Hum Vaccin Immunother; 2019; 15(3):677-682. PubMed ID: 30427738
[TBL] [Abstract][Full Text] [Related]
29. Antibody levels against polioviruses in children following Pulse Polio Immunization Program.
Hasan AS; Malik A; Shukla I; Malik MA
Indian Pediatr; 2004 Oct; 41(10):1040-4. PubMed ID: 15523131
[TBL] [Abstract][Full Text] [Related]
30. [Evaluation of the response to vaccination against poliomyelitis and measles in malnourished children in Morocco].
Caidi H; Bennis IF; Mouan N; El Aouad R
East Mediterr Health J; 2004; 10(4-5):474-81. PubMed ID: 16335637
[TBL] [Abstract][Full Text] [Related]
31. Immunity to poliovirus among children and the elderly in north-east Italy.
Majori S; Baldo V; Poli A; Riolfatti M; Alborino F; Bonello C; Frau S; Baldovin T; Dal Zotto A; Romano G; Trivello R
J Prev Med Hyg; 2006 Mar; 47(1):12-5. PubMed ID: 17061405
[TBL] [Abstract][Full Text] [Related]
32. 2001 serological survey in the Czech Republic--poliomyelitis.
Matyásová I; Rainetová P; Cástková J
Cent Eur J Public Health; 2003 Dec; 11 Suppl():S31-5. PubMed ID: 15080257
[TBL] [Abstract][Full Text] [Related]
33. Seroprevalence of poliovirus antibodies among 7-month-old infants after 4 doses of oral polio vaccine in Sistan-va-Baluchestan, Islamic Republic of Iran.
Izadi S; Shahmahmoodi S; Zahraei SM; Dorostkar F; Majdzadeh SR
East Mediterr Health J; 2015 Apr; 21(2):83-9. PubMed ID: 25876819
[TBL] [Abstract][Full Text] [Related]
34. Survey of poliovirus antibodies in Kano, Northern Nigeria.
Iliyasu Z; Nwaze E; Verma H; Mustapha AO; Weldegebriel G; Gasasira A; Wannemuehler KA; Pallansch MA; Gajida AU; Pate M; Sutter RW
Vaccine; 2014 Mar; 32(12):1414-20. PubMed ID: 24041545
[TBL] [Abstract][Full Text] [Related]
35. Immunity of the Croatian population to poliomyelitis--a serosurvey.
Borcić B; Kruzić V; Kaić B; Ljubin-Sternak S; Ljubicić M; Dobrovsak-Sourek V
Acta Med Croatica; 1998; 52(4-5):229-33. PubMed ID: 9988903
[TBL] [Abstract][Full Text] [Related]
36. Immune status to poliovirus among immigrant workers in Israel.
Calderon-Margalit R; Sofer D; Gefen D; Lewis M; Shulman L; Mendelson E; Swartz TA; Shohat T
Prev Med; 2005 Jun; 40(6):685-9. PubMed ID: 15850865
[TBL] [Abstract][Full Text] [Related]
37. Neutralizing antibodies against poliovirus serotypes among children in southwest Nigeria.
Adewumi MO; Donbraye E; Odaibo GN; Bakarey AS; Opaleye OO; Olaleye DO
J Trop Pediatr; 2006 Apr; 52(2):92-5. PubMed ID: 16014758
[TBL] [Abstract][Full Text] [Related]
38. Paralytic poliomyelitis in Oman: association between regional differences in attack rate and variations in antibody responses to oral poliovirus vaccine.
Sutter RW; Patriarca PA; Suleiman AJ; Pallansch MA; Zell ER; Malankar PG; Brogan S; al-Ghassani AA; el-Bualy MS
Int J Epidemiol; 1993 Oct; 22(5):936-44. PubMed ID: 8282476
[TBL] [Abstract][Full Text] [Related]
39. Long-Term Immunogenicity of Inactivated and Oral Polio Vaccines: An Italian Retrospective Cohort Study.
Larocca AMV; Bianchi FP; Bozzi A; Tafuri S; Stefanizzi P; Germinario CA
Vaccines (Basel); 2022 Aug; 10(8):. PubMed ID: 36016217
[TBL] [Abstract][Full Text] [Related]
40. Is EU/EEA population protected from polio?
Nijsten D; Carrillo-Santisteve P; Miglietta A; Ruitenberg J; Lopalco PL
Hum Vaccin Immunother; 2015; 11(9):2123-31. PubMed ID: 25898095
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
